What the regulator says
The Loniten SmPC, the UK product information for oral minoxidil, lists hypertrichosis as very common (affecting 1 in 10 people or more) and states: 'Hypertrichosis occurs in most patients treated with minoxidil and all patients should be warned of this possibility before starting therapy.' It says the signs 'usually' emerge 3 to 6 weeks after starting, that 'they initially emerge in the face', and that 'spontaneous reversal to the pre-treatment state can be expected one to six months after cessation of therapy.' These statements describe the licensed blood pressure doses. Low-dose oral minoxidil for hair loss is off-label in the UK, and the rates published at those lower doses are lower.
In plain English
Hypertrichosis means extra hair growing in places other than the scalp. With oral minoxidil it usually shows up as fine hairs becoming longer, thicker and darker, most often on the face (temples, forehead, cheeks, upper lip) and sometimes on the arms, legs or body. Taken by mouth, minoxidil reaches hair follicles all over the body, not just on the scalp. It is the most common side effect of low-dose oral minoxidil, and it is not a sign that anything harmful is happening.
How common is it at hair-loss doses? In the largest published safety study, a multicentre review of 1,404 patients taking low-dose oral minoxidil for hair loss (Vañó-Galván et al., Journal of the American Academy of Dermatology, 2021), hypertrichosis affected 15.1% of people, and 14 people (0.5%) stopped treatment because of it. A 2020 pooled analysis of 442 patients from 14 studies (Jimenez-Cauhe et al., Dermatologic Therapy) found it in 24%, with higher odds at every dose above 0.25 to 0.5 mg. A 2025 review of the evidence (Journal of Clinical Medicine) puts it at roughly 15%, more often in women and at higher doses.
Unwanted hair can also have other causes. In women, excessive facial or body hair (hirsutism) is one of the main symptoms of polycystic ovary syndrome, so new hair growth alongside irregular periods or acne is worth raising with your GP.
How long does it last
It tends to appear within the first weeks of treatment. The Loniten SmPC says signs usually emerge 3 to 6 weeks after starting and may slightly subside with continued treatment.
If the medicine is stopped, the SmPC expects the extra hair to return to its pre-treatment state within one to six months. Stopping also means any scalp benefit from minoxidil fades over the following months, so it is worth weighing both sides with your prescriber first. Our guide to stopping oral minoxidil explains what to expect.
What to do if it happens to you
Tell your prescriber. Unwanted hair is often manageable, and you do not have to put up with it in silence. Options your prescriber may discuss include the following.
Lowering the dose. Both large studies found hypertrichosis was linked to dose, so a smaller daily dose is often the first step. Our page on minoxidil oral tablets explains how the dose is set and reviewed.
Cosmetic management. Some people are content to trim, shave or wax the affected area and carry on, particularly if the hair is fine and light.
Changing route. Topical minoxidil applied to the scalp is another option, though it can also cause unwanted hair: the licensed UK SmPC lists hypertrichosis as common and notes it can be caused by the product transferring to areas other than the scalp. Our guide to oral and topical minoxidil sets out the practical differences.
Stopping. Choosing to stop is a valid decision, and the extra hair should settle over the following months.
You can report the side effect through the MHRA Yellow Card scheme, especially if it was severe or distressing. If unwanted hair appears alongside other new symptoms such as ankle swelling, a racing heartbeat or breathlessness, read oral minoxidil and ankle swelling and contact your prescriber promptly.
When to seek urgent care
Unwanted hair is not an emergency. But if you are taking oral minoxidil and develop sudden severe chest pain, breathlessness at rest, fainting, or palpitations with any of these, call 999 or go to A&E immediately.
Want bloods to help investigate?
If you would like a bloodwork baseline to support the clinical conversation about your symptoms, our sister diagnostic service WMG Health offers panels designed around the question you are asking. A clinician-designed custom panel (from £275) is usually the best route when the question is specific.
Same Westminster Medical Group, single clinical record, results visible to your WMG Meds prescriber.